Mainieri Alberto Scofano, Elnecave Regina Helena
Adolescent Medical Service and Endocrinology Service, Hospital de Clínicas de Porto Alegre, Brazil.
Clin Endocrinol (Oxf). 2003 Sep;59(3):307-13. doi: 10.1046/j.1365-2265.2003.01845.x.
Differentiating constitutional delay of growth and puberty from hypogonadotropic hypogonadism is still a problem in clinical practice. Our previous study demonstrated that the peak/basal ratio of the free alpha-subunit of the glycoprotein hormones is higher in normal prepubertal boys than in male adults with hypogonadotropic hypogonadism. The objective of this study was to assess the performance of this ratio in normal male patients at different ages and levels of pubertal development, and in patients with hypogonadotropic hypogonadism, both isolated and combined with other pituitary hormone deficiencies.
Cohort study.
Twenty-eight normal prepubertal males between 6 and 8 years; 20 normal prepubertal males between 9 and 13 years; 18 males with constitutional delay of growth and puberty; 26 normal pubertal males; 13 adult men with isolated hypogonadotropic hypogonadism; 21 adult men with complete hypogonadotropic hypogonadism combined with other hormone deficiencies; and 11 adult men with partial hypogonadotropic hypogonadism combined with other hormone deficiencies.
Serum levels of free alpha-subunit immediately before (basal), and 30 and 60 min after 100 micro g intravenous GnRH were measured by immunofluorimetry. Median and P25-P75 range of the peak/basal ratio of the free alpha-subunit was determined for each group. A receiver operating characteristics curve was calculated. Results were compared using the Kruskal-Wallis test.
The peak/basal ratio of the free alpha-subunit was higher in patients with constitutional delay of growth and puberty (7.46) than in those with isolated hypogonadotropic hypogonadism (2.73), complete combined hypogonadotropic hypogonadism (1.58), and partial combined hypogonadotropic hypogonadism (2.61; P < 0.001). A peak/basal ratio < 3.26 identified hypogonadotropic hypogonadism with 93.2% sensitivity and 94.4% specificity when compared to constitutional delay of growth and puberty. There was no statistical difference between the peak/basal ratio of prepubertal patients between 6 and 8 years (7.20), patients between 8 and 13 years (8.71), normal pubertal males (8.10) and those with constitutional delay of growth and puberty (7.46). In a group of boys with delayed puberty, a cut-off point of 3.69 defined hypogonadotropic hypogonadism with 95.6% sensitivity and 94.4% specificity. A cut-off point of 4.81 gave 100% sensitivity (88.9% specificity), and 3.09 gave 100% specificity (86.7% sensitivity).
The peak/basal ratio of the free alpha-subunit can be used for the differential diagnosis of constitutional delay of growth and puberty and hypogonadotropic hypogonadism, irrespective of age. This distinction allows early investigation and treatment of patients with hypogonadotropic hypogonadism and reassurance for those with constitutional delay of growth and puberty.
在临床实践中,区分体质性生长和青春期发育延迟与低促性腺激素性性腺功能减退仍然是一个难题。我们之前的研究表明,正常青春期前男孩糖蛋白激素游离α亚基的峰值/基础值比值高于低促性腺激素性性腺功能减退的成年男性。本研究的目的是评估该比值在不同年龄和青春期发育水平的正常男性患者以及低促性腺激素性性腺功能减退患者(包括孤立性和合并其他垂体激素缺乏的患者)中的表现。
队列研究。
28名6至8岁的正常青春期前男性;20名9至13岁的正常青春期前男性;18名体质性生长和青春期发育延迟的男性;26名正常青春期男性;13名孤立性低促性腺激素性性腺功能减退的成年男性;21名合并其他激素缺乏的完全性低促性腺激素性性腺功能减退的成年男性;11名合并其他激素缺乏的部分性低促性腺激素性性腺功能减退的成年男性。
通过免疫荧光法测量静脉注射100μg促性腺激素释放激素(GnRH)前(基础值)以及注射后30分钟和60分钟时的血清游离α亚基水平。确定每组游离α亚基峰值/基础值比值的中位数和P25 - P75范围。计算受试者工作特征曲线。使用Kruskal - Wallis检验比较结果。
体质性生长和青春期发育延迟患者的游离α亚基峰值/基础值比值(7.46)高于孤立性低促性腺激素性性腺功能减退患者(2.73)、完全性合并低促性腺激素性性腺功能减退患者(1.58)和部分性合并低促性腺激素性性腺功能减退患者(2.61;P < 0.001)。与体质性生长和青春期发育延迟相比,峰值/基础值比值< 3.26诊断低促性腺激素性性腺功能减退的敏感性为93.2%,特异性为94.4%。6至8岁青春期前患者(7.20)、8至13岁患者(8.71)、正常青春期男性(8.10)和体质性生长和青春期发育延迟患者(7.46)的游离α亚基峰值/基础值比值之间无统计学差异。在一组青春期延迟的男孩中,截止值为3.69诊断低促性腺激素性性腺功能减退的敏感性为95.6%,特异性为94.4%。截止值为4.81时敏感性为100%(特异性为88.9%),截止值为3.09时特异性为100%(敏感性为86.7%)。
游离α亚基的峰值/基础值比值可用于体质性生长和青春期发育延迟与低促性腺激素性性腺功能减退的鉴别诊断,与年龄无关。这种区分有助于对低促性腺激素性性腺功能减退患者进行早期检查和治疗,并让体质性生长和青春期发育延迟患者放心。